We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
+2.62%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$29.7B
AUM Growth
+$1.97B
Cap. Flow
+$1.27B
Cap. Flow %
4.28%
Top 10 Hldgs %
54.74%
Holding
2,185
New
207
Increased
867
Reduced
691
Closed
168

Sector Composition

Rank Sector Weight
1 Financials 4.86%
2 Technology 4.06%
3 Healthcare 2.07%
4 Industrials 1.87%
5 Consumer Discretionary 1.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FEZ icon
1526
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.28B
$231K ﹤0.01%
6,027
+27
+0.5% +$1.02K
GAIN icon
1527
Gladstone Investment Corp
GAIN
$635M
$231K ﹤0.01%
20,555
+450
+2% +$5.34K
CXO
1528
DELISTED
CONCHO RESOURCES INC.
CXO
$231K ﹤0.01%
2,237
-2,420
-52% -$261K
MLI icon
1529
Mueller Industries
MLI
$14.1B
$230K ﹤0.01%
+31,448
New +$230K
NQP
1530
DELISTED
Nuveen Pennsylvania Quality Municipal Income Fund
NQP
$230K ﹤0.01%
16,870
DWM icon
1531
WisdomTree International Equity Fund
DWM
$666M
$229K ﹤0.01%
4,499
-109
-2% -$5.54K
GGT
1532
Gabelli Multimedia Trust
GGT
$170M
$229K ﹤0.01%
28,829
-736
-2% -$5.98K
DISCK
1533
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$229K ﹤0.01%
+8,058
New +$219K
IMO icon
1534
Imperial Oil
IMO
$62.1B
$228K ﹤0.01%
8,255
-1,140
-12% -$32K
CTSO icon
1535
Cytosorbents Corp
CTSO
$22.6M
$227K ﹤0.01%
34,390
MMSI icon
1536
Merit Medical Systems
MMSI
$4.43B
$227K ﹤0.01%
3,803
+129
+4% +$7.4K
MFNC
1537
DELISTED
Mackinac Financial Corporation
MFNC
$227K ﹤0.01%
14,343
IVOO icon
1538
Vanguard S&P Mid-Cap 400 ETF
IVOO
$3.73B
$225K ﹤0.01%
3,430
-200
-6% -$12.9K
TRMK icon
1539
Trustmark
TRMK
$2.73B
$225K ﹤0.01%
6,767
-3,306
-33% -$112K
YTRA icon
1540
Yatra Online
YTRA
$54.7M
$225K ﹤0.01%
60,173
+25,000
+71% +$110K
PCSB
1541
DELISTED
PCSB Financial Corporation
PCSB
$225K ﹤0.01%
11,100
+1,100
+11% +$21.3K
RDN icon
1542
Radian Group
RDN
$5.14B
$224K ﹤0.01%
+9,816
New +$224K
ZBRA icon
1543
Zebra Technologies
ZBRA
$12.4B
$224K ﹤0.01%
+1,069
New +$216K
EBIX
1544
DELISTED
Ebix Inc
EBIX
$224K ﹤0.01%
4,467
BLCM
1545
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$223K ﹤0.01%
13,098
AWF
1546
AllianceBernstein Global High Income Fund
AWF
$867M
$222K ﹤0.01%
18,803
+4,609
+32% +$53.8K
BIO icon
1547
Bio-Rad Laboratories Class A
BIO
$8.42B
$222K ﹤0.01%
711
-12
-2% -$3.59K
INDY icon
1548
iShares S&P India Nifty 50 Index Fund
INDY
$545M
$222K ﹤0.01%
5,775
+27
+0.5% +$1.03K
PBR icon
1549
Petrobras
PBR
$121B
$222K ﹤0.01%
14,269
-558
-4% -$8.51K
USCI icon
1550
US Commodity Index
USCI
$372M
$222K ﹤0.01%
6,018
-200
-3% -$7.55K

Similar funds

Creative Planning's Q2 2019 Portfolio in Review

As of Q2 2019, Creative Planning held 2,185 positions worth $29.7B, up 7.1% from $27.8B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Creative Planning deployed $1.27B of net new capital in Q2 2019, opening 207 new positions and adding to 867 existing holdings. Its largest new stake was Dow Inc: 108,999 shares worth $5.38M.

By sector, the portfolio is most concentrated in Financials at 4.9% of assets, up from 4.7% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Vanguard Mid-Cap ETF, an estimated $115M trimmed.

  • Creative Planning's largest Q2 2019 buy was Dow Inc: 108,999 shares worth $5.38M.
  • Creative Planning added most to iShares Core US Aggregate Bond ETF in Q2 2019, an estimated $297M increase.
  • Creative Planning's biggest Q2 2019 reduction was Vanguard Mid-Cap ETF, cutting an estimated $115M.
  • Creative Planning fully exited Intercept Pharmaceuticals, Inc. in Q2 2019, selling an estimated $3.71M.
  • Creative Planning's ten largest holdings make up 55% of its $29.7B portfolio in Q2 2019.
  • Creative Planning opened 207 new positions and closed 168 in Q2 2019.
  • Creative Planning's portfolio value rose 7.1% quarter-over-quarter to $29.7B.

Based on Creative Planning's 13F filing for Q2 2019, filed 26 Jul 2019.